Tag : New Drug Application

Latest News

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Newsemia
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva®...
Latest News

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

Newsemia
Novartis today announced that both the US Food and Drug Administration and European Medicines Agency have accepted the company’s New Drug Application and Marketing Authorization...
Gastroenterology

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Newsemia
Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy